BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11932904)

  • 1. Changing incidence of non-Hodgkin lymphomas in the United States.
    Clarke CA; Glaser SL
    Cancer; 2002 Apr; 94(7):2015-23. PubMed ID: 11932904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.
    Groves FD; Linet MS; Travis LB; Devesa SS
    J Natl Cancer Inst; 2000 Aug; 92(15):1240-51. PubMed ID: 10922409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
    Wu XC; Andrews P; Chen VW; Groves FD
    Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
    Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
    Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988.
    Zheng T; Mayne ST; Boyle P; Holford TR; Liu WL; Flannery J
    Cancer; 1992 Aug; 70(4):840-9. PubMed ID: 1643616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease.
    Medeiros LJ; Greiner TC
    Cancer; 1995 Jan; 75(1 Suppl):357-69. PubMed ID: 8001007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.
    Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1295-300. PubMed ID: 16835326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing incidence of non-Hodgkin's lymphoma in Karachi, 1995-2002.
    Bhurgri Y; Pervez S; Bhurgri A; Faridi N; Usman A; Kazi LA; Ahmed R; Kayani N; Hasan SH
    Asian Pac J Cancer Prev; 2005; 6(3):364-9. PubMed ID: 16236001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin's lymphoma.
    Greiner TC; Medeiros LJ; Jaffe ES
    Cancer; 1995 Jan; 75(1 Suppl):370-80. PubMed ID: 8001008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence.
    Cleghorn FR; Manns A; Falk R; Hartge P; Hanchard B; Jack N; Williams E; Jaffe E; White F; Bartholomew C
    J Natl Cancer Inst; 1995 Jul; 87(13):1009-14. PubMed ID: 7629870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century.
    Pulte D; Gondos A; Brenner H
    Arch Intern Med; 2008 Mar; 168(5):469-76. PubMed ID: 18332290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.
    Shiels MS; Engels EA; Linet MS; Clarke CA; Li J; Hall HI; Hartge P; Morton LM
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1069-78. PubMed ID: 23595542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology.
    Müller AM; Ihorst G; Mertelsmann R; Engelhardt M
    Ann Hematol; 2005 Jan; 84(1):1-12. PubMed ID: 15480663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly increasing incidence of ocular non-hodgkin lymphoma.
    Moslehi R; Devesa SS; Schairer C; Fraumeni JF
    J Natl Cancer Inst; 2006 Jul; 98(13):936-9. PubMed ID: 16818858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global burden, risk factors, and trends of non-Hodgkin lymphoma: A worldwide analysis of cancer registries.
    Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS
    Cancer Med; 2024 Mar; 13(5):e7056. PubMed ID: 38477498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
    Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
    Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.
    Rabbani F; Russo P
    Urology; 1999 Jul; 54(1):28-33. PubMed ID: 10414722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.